Currently, AI technology is maturing and making breakthroughs in the medical and healthcare field, and AI combined with medical imaging, assisted diagnosis, and empowering new drug research and development application scenarios continue to land. 2020 China's investment in the AI medical field reached 6.409 billion yuan, a year-on-year increase of 141.9%, and technology giants such as Tencent, Ali, and Huawei have entered the field. have entered the game.
What's even more gratifying is that AI medical imaging in the field of healthcare continues to gain commercialization success. Ma Chun'e, co-founder and CEO of Numarkun Technology, revealed at the summit that Numarkun Technology's AI products have been used by clinicians in tertiary and primary hospitals with high frequency, and Numarkun is working to expand the use of AI products in primary hospitals to help more grassroots patients enjoy higher quality healthcare resources as soon as possible.
The future is here, AI+Medicine is leading the new trend of digital healthcare
The integration of emerging technologies and medical and healthcare industries is accelerating, and the capital market is also opening its doors to innovative medical technology companies. As a result, AI healthcare has also become the highlight of the summit.
"In the hospital space, the early application of ambient intelligence can make clinical workflows more efficient and improve patient safety in intensive care units and operating rooms," argued Stanford professor Fei-Fei Li, adding that for the future of the home scenario, where the majority of seniors will spend most of their time at home, AI sensors will be able to help seniors become more independent in their daily lives, and manage chronic diseases and treatments for physical rehabilitation through daily data collection.
With Prof. Feifei Li's perfect opening on the topic of AI healthcare, leading domestic AI companies such as Huawei, Tencent, Baidu, Nukun Technology, and Tech Data Xunfei brought the discussion on the future trend of "AI+Healthcare" to a climax.
Wu Wenda, an expert of the World Health Organization's Digital Health Technology Advisory Committee and vice president of Tencent Healthcare, believes that AI images are now in short supply and have improved the efficiency of many doctors.
Tao Xiaodong, president of KDDI Healthcare, also believes that medical AI still serves doctors and patients in essence. "AI has already shown its value in many areas, including assisted diagnosis, imaging, and accurate matching of patients and doctors. In the future, AI will show its value in more and more scenarios to help patients and doctors."
"The combination of AI and healthcare will have the potential to improve the efficiency of different links in the entire healthcare industry chain, from genomics research, to the screening and development of vaccines and drugs, to clinical assisted diagnosis," said Yuan Jing, Vice President of Huawei Cloud's Artificial Intelligence field.
In the view of Ma Chun'e, co-founder and CEO of Numarkun Technology, the scarcity of medical resources, uneven distribution and other realities of the problem so that many people can not see the disease, and the beauty of the AI technology is to make every ordinary person, can be fair to enjoy the medical services, which is the mission of the AI medical enterprise, I hope Numarkun Technology in the future in the wisdom of the health care to do the greatest contribution.
Solving the pain points, NIKKUN AI has been used by clinicians with high frequency
For many startups, the application of AI in the field of medical diagnosis and treatment faces competition from Internet giants, but not many companies can really realize commercialization in the medical field, NIKKUN is undoubtedly the earliest to realize the clinical value of an AI enterprise.
A few years ago, Ma Chun'e saw a high degree of homogenization of products on the market, focusing on lung nodules, sugar network screening. She firmly believed that the long-term commercialization success will only be products with great clinical value. 2020 end, the number of Kun technology to obtain the world's first cardiac coronary artery stenosis AI medical device class III certificate, has been rapidly deployed in more than 600 hospitals across the country.
In addition, most of the domestic AI imaging products are based on two-dimensional medical images to develop auxiliary diagnostic products. In contrast, NIKKUN Technology has constructed "digital heart", "digital brain", "digital lung", "digital abdomen" and other products under the idea of building a digital human body. "
The company's products have been developed to meet the needs of the public and the private sector.
Ma Chun'e introduction, the number of Kun science and technology in the construction of the "digital heart", first of all, the reconstruction of the tomography, three-dimensional way to establish a complete heart, doctors can do further diagnosis. This is not a plaque detection in the heart, doctors need to do a lot of work.
Ma Chun'e said, the number of Kun team from the above knowledge, first of all, the organ digitization, for example, when doing head and neck products, the first head and neck of the entire anatomical structure of the digitization, and then simulate the diagnostic thinking of the imaging doctor to find anomalies in the structure, the abnormalities to do a qualitative and quantitative analysis, and finally write a report, which can be in line with the thinking mode of the imaging doctor's work.
"So after our digital heart was deployed to clinical daily work, doctors liked it very much, and we did digital brain and other products along this line," said Ma Chun'e. "Detection of lesions is a relatively simple task from a technical point of view, but it can provide certain value, and we are thinking about how we can deepen the value of our products and make products that clinicians particularly like, especially to address more diagnostics in complex scenarios like heart and brain."
Another big reason why clinicians like Numarkun AI is that the intervention of AI has reconfigured the workflow of imaging diagnosis and treatment, from scanning images to structured reports, which can be shortened from two or three hours in the past to two or three minutes now, which allows clinicians to greatly save time, and allows more patients to reduce the queuing time.
AI landing more ordinary people to enjoy high-quality health care
Solving the pain points of clinicians, commercialization naturally comes to the fore.
Ma Chun'e said, last year, after the cardiovascular AI diagnostic products of the number of Kun was certified, many hospitals are willing to purchase on their own, and there are other hospitals in the negotiation of the procurement contract with the supplier of large equipment hope that the equipment vendors with the number of Kun's products, the hospital to make purchases. More and more equipment manufacturers take the initiative to start strategic cooperation with Numakun, Numakun doesn't need to sell the products one by one, and the vendors of big equipments with Numakun AI products as standard can also enhance their value, and give better solutions to customers.
Ma Chun'e said, the number of Kun hope to realize every image can be AI-assisted generation of reports, every surgery can be AI products for it to do auxiliary surgery planning. And commercialization is just the process of quantitative change to qualitative change, more ordinary people will also enjoy the quality of the big three medical resources faster.
In order to realize this goal, Nukun Technology has rapidly deployed channel sinking, and continuously promoted AI to grassroots county hospitals.
According to People's Daily Health Client, in December last year, the People's Hospital of Xinghua City, Jiangsu Province, at the end of December last year, the introduction of the number of Kun science and technology research and development and production of the digital brain, digital heart, digital lung AI imaging system, after two days of training, the hospital's imaging doctors will be able to skillfully use the system for intelligent diagnosis of patients.
Liu Xingming, director of the hospital's CT room, said, "After the hospital introduced the artificial intelligence-assisted diagnosis system for coronary artery and head and neck CTA of Digital Kun Technology, it is very helpful for improving medical efficiency and quality, and is now used in clinical high frequency every day. And some of the difficult cases, patients are not quite assured of our diagnosis, when they heard that the artificial intelligence and doctors *** with the report issued, patients instead of eliminating doubts."
Keeping patients at home, freeing imaging doctors from cumbersome reading, and bringing the experience of tertiary hospital doctors to the grassroots, AI effectively improves the diagnostic capabilities of grassroots hospitals, allowing the system of hierarchical diagnosis and treatment to really take root in grassroots hospitals and patients.
Nowadays, AI has become an indispensable medical diagnostic tool for many doctors, and has formed a highly viscous relationship with both the doctor's end and the patient's end. And this kind of dependence and high viscosity, is the investment institutions are most concerned about the investment decision-making basis. On December 28th last year, Nukun completed a new round of financing of 590 million RMB, which was led by Sequoia Capital China Fund. Last year, Nukun completed nearly 1 billion yuan of financing, and became the leader in the field of AI imaging.